Durability of the TearCare treatment effect in subjects with dry eye disease: Stage 3 of the Sahara randomized controlled trial.
| Publicado en: | Optometry & Vision Science Vol. 102; no. 8; pp. 495 - 505 |
|---|---|
| Autores principales: | , , , , , , , , , |
| Formato: | Journal Article |
| Publicado: |
Wiley-Blackwell
Aug2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=187149385&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 187149385 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 10405488 1X24 jtl: Optometry & Vision Science issn: 10405488 maglogo: N pubinfo: dt: Aug2025 vid: 102 iid: 8 pid: 480 pub: Wiley-Blackwell place: Malden, Massachusetts artinfo: ui: 187149385 10.1097/OPX.0000000000002278 187149385 ppf: 495 ppct: 10 formats: tig: atl: Durability of the TearCare treatment effect in subjects with dry eye disease: Stage 3 of the Sahara randomized controlled trial. aug: au: Hovanesian, John Ayres, Brandon D. Bloomenstein, Marc R. Loh, Jennifer Chester, Thomas Saenz, Bobby Echegoyen, Julio Kannarr, Shane R. Rodriguez, Tomasita C. Dickerson Jr., Jaime E. affil: Harvard Eye Associates, Laguna Hills, California sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|